The Celiac Disease Genomic Environmental Microbiome and Metabolomic Study
CDGEMM: Studio sulla malattia celiaca
Benvenuto! CDGEMM sta per Celiac Disease Genomic Environmental Microbiome and Metabolomic Study (Studio Genomico Ambientale Microbiomico e Metabolomico nella Malattia Celiaca) e recluta bambini che hanno un parente di primo grado con celiachia.
- About CDGEMM
- How CDGEMM Is Making History
- About Celiac Disease
- CDGEMM Frequently Asked Questions
- How to get involved
- Participating centers
- Gut Microbiota in Infants: First Results from the CDGEMM Study
The CDGEMM Study is currently recruiting infants in the womb or aged up to 6 months who have a first-degree relative (parent or sibling) with celiac disease.
For general questions about the CDGEMM study, email CDGEMM@mgh.harvard.edu. To enroll, or inquire about enrollment, please contact a participating center nearest you.
For study updates and more information from the Center for Celiac Research and Treatment, visit us on social media! You can also find details about the CDGEMM study on clinicaltrials.gov and on the Mass General Brigham clinical trials registration page.
Interested in sharing information about CDGEMM in your healthcare setting?
This flyer can be posted or distributed freely to any interested care providers or potential participants. Thank you for helping to spread the word about CDGEMM!
Meet the Team
- Alessio Fasano, MD
- Maureen Leonard, MD
- Mark A. Salvatore, MD
- Martha Pacetti, RN, MSN, CPNP
- Pam Cureton, RD, LDN
- Gloria Serena, PhD
- Victoria Kenyon, Clinical Research Coordinator
As of February 2021, the CDGEMM Study has enrolled 235 infants in the United States and 266 in Italy for a total of 501 infants. Check out our recent newsletters below for additional updates on study progress.
Got Comments? CDGEMM participants and care providers are encouraged to submit comments or concerns about the study through this anonymous portal. We love to hear your feedback!